Pfizer Vaccine Only Slightly Less Effective Against Key S. African Mutations: Study

Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to lose only a small bit of effectiveness against an engineered virus with three key mutations from the new coronavirus variant found in South Africa, according to a laboratory study conducted by the U.S. drugmaker.